16hon MSN
Mentally ill people are stuck in jail because they can't get treatment. Here's what's to know
Fernando Clark spent the last 10 months of his life in an Alabama jail cell, waiting for court-ordered psychiatric treatment ...
Caplyta, the crown jewel of Johnson & Johnson's $14.6 billion buyout of Intra-Cellular Therapies, won the FDA’s blessing to ...
Adoptees’ higher ADHD rates reflect genetic, prenatal, and social factors, highlighting the need for trauma-informed, adoption-competent care and systemic equity.
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug Caplyta as an add-on treatment for adults with major depressive disorder, the company said on Thursday.
Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...
Attention deficit hyperactivity disorder, or ADHD, is a long-term neurodevelopmental disorder usually found and diagnosed in ...
MedPage Today on MSN
Novel Oral Treatment Reduced Liver Fat in MASH
WASHINGTON -- Daily treatment with the investigational oral agent HU6 reduced liver fat and body weight without muscle loss in patients with metabolic dysfunction-associated steatohepatitis (MASH), ...
Medium on MSN
7 Foods That Can Trigger ADHD
Certain foods can trigger your ADHD. To better control impulses, you will want to limit your consumption of these ADHD triggering foods.
She explained that even a small error, such as taking a double dose of clonidine, could send a child to hospital. ‘The sharp ...
Grown & Flown on MSN
Christmas Gift Guide for Young Adult Women in College, Careers (2025)
We are a reader-supported site and receive compensation from purchases made through these links. See more about our Privacy ...
The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results